7,507 Shares in Teleflex Incorporated (NYSE:TFX) Purchased by Siemens Fonds Invest GmbH

Siemens Fonds Invest GmbH acquired a new position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 7,507 shares of the medical technology company's stock, valued at approximately $1,336,000.

A number of other institutional investors have also made changes to their positions in the stock. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Teleflex during the fourth quarter worth $6,528,000. Jefferies Financial Group Inc. grew its stake in shares of Teleflex by 9.3% during the fourth quarter. Jefferies Financial Group Inc. now owns 4,837 shares of the medical technology company's stock worth $861,000 after purchasing an additional 412 shares during the period. Mackenzie Financial Corp grew its stake in shares of Teleflex by 59.2% during the fourth quarter. Mackenzie Financial Corp now owns 36,281 shares of the medical technology company's stock worth $6,457,000 after purchasing an additional 13,488 shares during the period. Forum Financial Management LP grew its stake in shares of Teleflex by 48.6% during the fourth quarter. Forum Financial Management LP now owns 1,293 shares of the medical technology company's stock worth $230,000 after purchasing an additional 423 shares during the period. Finally, Toronto Dominion Bank grew its stake in shares of Teleflex by 5.9% during the fourth quarter. Toronto Dominion Bank now owns 24,961 shares of the medical technology company's stock worth $4,443,000 after purchasing an additional 1,395 shares during the period. 95.62% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

TFX has been the subject of a number of analyst reports. Raymond James cut Teleflex from an "outperform" rating to a "market perform" rating in a research note on Friday, February 28th. Wells Fargo & Company decreased their price objective on Teleflex from $146.00 to $137.00 and set an "equal weight" rating for the company in a research note on Friday, May 2nd. Morgan Stanley decreased their target price on Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a research note on Monday, May 5th. Mizuho set a $155.00 target price on Teleflex in a research note on Wednesday, April 16th. Finally, Bank of America cut Teleflex from a "neutral" rating to an "underperform" rating and decreased their target price for the company from $235.00 to $140.00 in a research note on Tuesday, March 4th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, Teleflex has a consensus rating of "Hold" and an average price target of $164.63.

Teleflex Stock Down 0.3%

Shares of Teleflex stock traded down $0.34 during trading on Friday, reaching $122.19. The stock had a trading volume of 683,821 shares, compared to its average volume of 629,565. The company has a market capitalization of $5.40 billion, a price-to-earnings ratio of 24.29, a P/E/G ratio of 1.73 and a beta of 1.17. The stock has a fifty day moving average price of $129.59 and a two-hundred day moving average price of $157.49. Teleflex Incorporated has a 52 week low of $119.08 and a 52 week high of $249.91. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, beating analysts' consensus estimates of $2.88 by $0.03. The company had revenue of $700.67 million for the quarter, compared to analyst estimates of $699.37 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company's quarterly revenue was down 5.0% compared to the same quarter last year. During the same period in the previous year, the company posted $3.21 earnings per share. Sell-side analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Stockholders of record on Tuesday, May 20th will be issued a $0.34 dividend. The ex-dividend date is Tuesday, May 20th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.11%. Teleflex's dividend payout ratio (DPR) is 42.90%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.